Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

NCT01580696 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

FED

Sponsor class

Conditions

Ovarian Cancer
Endometrial Cancer
Fallopian Cancer
Peritoneal Cancer

Interventions

BIOLOGICAL: E39 peptide (100mcg)/GM-CSF vaccine plus E39 booster
OTHER: Non-vaccine clinically matched control group
BIOLOGICAL: E39 peptide (500mcg)/GM-CSF vaccine plus E39 booster
BIOLOGICAL: E39 peptide (1000mcg)/GM-CSF vaccine plus E39 booster
BIOLOGICAL: E39 peptide (100mcg)/GM-CSF vaccine plus J65 booster
BIOLOGICAL: E39 peptide (500mcg)/GM-CSF vaccine plus J65 booster
BIOLOGICAL: E39 peptide (1000mcg)/GM-CSF vaccine plus J65 booster

Sponsor

COL George Peoples, MD, FACS